[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Market for Pain Management Patches

June 2020 | 136 pages | ID: G0BFD4B0D07BEN
BCC Research

US$ 4,675.00 US$ 5,500.00 -15 %
Offer valid until September 30, 2020!

E-mail Delivery (PDF)

Download PDF Leaflet

Wire Transfer
Checkout Later
Need Help? Ask a Question
REPORT SCOPE:

The current report offers a detailed picture of the pain relief patch market. Opioid and NSAID pain management patches have been analyzed in the report, and patch regulations and demand for addressing different types of pain have been included in the scope of the study. The report excludes drugs used in the treatment of hormonal pain. The market size includes both branded and generic drugs.

The report highlights the current and future market potential of pain management patches and provides a detailed analysis of the competitive environment, regulatory scenario, drivers, restraints, opportunities and trends in the market. The report also covers market projections through 2023, as well as market shares for key market players.

The report details market shares of pain management patches based on drug, major segment, application and geography.

Based on drug, the market is segmented into fentanyl patches, buprenorphine, lidocaine, diclofenac, ketoprofen, capsaicin, methyl salicylate, menthol and others (glycol salicylate, tocopherol acetate, camphor, etc.).

Based on major segment, the market is segmented into over the counter (OTC) and prescription.

Based on category of pain, the market is segmented into acute pain and chronic pain.

By geography, the market has been segmented into North America, Europe, Asia-Pacific and Rest of the World. Detailed analyses of major countries such as the U.S., Canada, Mexico, Germany, the U.K., France, Spain, Italy, Japan, China, Australia, New Zealand and India are covered in regional segments. For market estimates, data has been provided for the year 2017 as the base year, with forecasts for 2018 through 2023. Estimated values used are based on drug manufacturers’ total revenues. Projected and forecasted revenue values are in constant U.S. dollars, unadjusted for inflation.

REPORT INCLUDES:
  • 31 data tables and 15 additional tables
  • An overview of the global market for pain management drugs used in the form of patches for immediate relief from any type of pain
  • Analyses of global market trends, with market data from 2017, 2018, and projections of compound annual growth rates (CAGRs) through 2023
  • Assessment of current market size, market forecast, and main driving forces for the pain relief patches market
  • Briefing about antihypertensive drugs, their pathophysiology and pathogenesis and major adverse effects of various antihypertensive drugs
  • Information on significant products, issues and trends, market influences, regulatory issues and other information affecting the pain relief patches market
  • Profile description of major market players including Endo Pharmaceuticals Inc., GlaxoSmithKline PLC, Hisamitsu Pharmaceutical Co. Inc., Johnson & Johnson, Novartis AG, Pfizer Inc., and Sanofi
CHAPTER 1 INTRODUCTION

Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
Information Sources
Methodology
Geographic Breakdown
Analyst’s Credentials
BCC Custom Research
Related BCC Research Reports

CHAPTER 2 SUMMARY AND HIGHLIGHTS

CHAPTER 3 MARKET AND TECHNOLOGY BACKGROUND

Pain Management Patches
Pathophysiology and Pathogenesis
Topical Preparations and Topical Delivery Systems
Prevalence of Chronic Pain
Trends in Pain Management Patches

CHAPTER 4 MARKET DYNAMICS

Market Drivers
Increasing Incidence of Acute and Chronic Pain
Rise in Geriatric Population and Related Orthopedic Surgery
Developments in Transdermal Patch Design
Emerging Non-opioid Drugs for Pain Management
Market Restraints
Side Effects of Pain Management Patches
High Cost of Drug Development and Pricing Pressures on Manufacturers
Market Opportunities
Launch of New Patches for Pain Management
Rise in Number of Therapeutically Active Substances for Transdermal Patches

CHAPTER 5 MARKET BREAKDOWN BY THE DRUG USED

Introduction
Fentanyl
Market Size and Forecast
Market Analysis
Buprenorphine
Market Size and Forecast
Market Analysis
Lidocaine
Market Size and Forecast
Market Analysis
Diclofenac
Market Size and Forecast
Market Analysis
Ketoprofen
Market Size and Forecast
Market Analysis
Capsaicin
Market Size and Forecast
Market Analysis
Methyl Salicylate
Market Size and Forecast
Market Analysis
Menthol
Market Size and Forecast
Market Analysis
Others
Market Size and Forecast
Market Analysis

CHAPTER 6 MARKET BREAKDOWN BY MAJOR SEGMENT

Introduction
Over the Counter (OTC)
Market Size and Forecast
Prescription
Market Size and Forecast

CHAPTER 7 MARKET BREAKDOWN BY CATEGORY OF PAIN

Introduction
Acute Pain
Market Size and Forecast
Market Analysis
Chronic Pain
Market Size and Forecast
Market Analysis

CHAPTER 8 MARKET BREAKDOWN BY REGION

Introduction
North America
United States
Canada
Europe
Germany
France
United Kingdom
Italy
Spain
Rest of Europe
Asia-Pacific
Japan
China
India
Australia and New Zealand
Rest of Asia-Pacific
Rest of World
Market Size and Forecast
Market Analysis

CHAPTER 9 REGULATORY ENVIRONMENT

Regulations in the U.S.
New Drug Approvals
FDA Modernization Act of 1997
Fast Track Status
Special Protocol Assessments
Medicaid and Medicare
Principles for Clinical Evaluation of New Pain Management Patches
Regulations in Europe
Pricing and Reimbursement
Regulations in Japan
Regulations in China
Regulations in India

CHAPTER 10 COMPETITIVE LANDSCAPE

Global Analysis of Company Shares
Mergers and Acquisitions
Agreements, Collaborations and Partnerships
Market Impact of Generic Pain Management Patches

CHAPTER 11 COMPANY PROFILES

ENDO PHARMACEUTICALS INC.
GLAXOSMITHKLINE PLC
GRUNENTHAL
HISAMITSU PHARMACEUTICAL CO. INC.
ICURE PHARMA INC.
JOHNSON & JOHNSON
MYLAN N.V.
NOVARTIS AG
PFIZER INC.
SANOFI
SPARSHA PHARMA INTERNATIONAL PVT. LTD.
TEVA PHARMACEUTICAL INDUSTRIES LTD.

CHAPTER 12 APPENDIX: ACRONYMS

LIST OF TABLES

Summary Table: Global Market for Pain Management Patches, by the Drug Used, Through 2023
Table 1: Classification of Pain Management Patches
Table 2: Global Market for Pain Management Patches, by the Drug Used, Through 2023
Table 3: Global Market for Fentanyl Pain Management Patches, by Region, Through 2023
Table 4: Global Market for Buprenorphine Pain Management Patches, by Region, Through 2023
Table 5: Global Market for Lidocaine Pain Management Patches, by Region, Through 2023
Table 6: Global Market for Diclofenac Pain Management Patches, by Region, Through 2023
Table 7: Global Market for Ketoprofen Pain Management Patches, by Region, Through 2023
Table 8: Global Market for Capsaicin Pain Management Patches, by Region, Through 2023
Table 9: Global Market for Methyl Salicylate Pain Management Patches, by Region, Through 2023
Table 10: Global Market for Menthol Pain Management Patches, by Region, Through 2023
Table 11: Global Market for Other Types of Pain Management Patches, by Region, Through 2023
Table 12: Products Categorized into OTC and Prescription Drugs
Table 13: Global Market for Over-the-Counter Pain Management Patches, by Region, Through 2023
Table 14: Global Market for Prescription Pain Management Patches, by Region, Through 2023
Table 15: Global Market for Pain Management Patches for Acute Pain, by Region, Through 2023
Table 16: Global Market for Pain Management Patches for Chronic Pain, by Region, Through 2023
Table 17: Global Market for Pain Management Patches, by Region, Through 2023
Table 18: North American Market for Pain Management Patches, by the Drug Used, Through 2023
Table 19: North American Market for Pain Management Patches, by Major Segment, Through 2023
Table 20: North American Market for Pain Management Patches, by Category of Pain, Through 2023
Table 21: North American Market for Pain Management Patches, by Country, Through 2023
Table 22: European Market for Pain Management Patches, by the Drug Used, Through 2023
Table 23: European Market for Pain Management Patches, by Major Segment, Through 2023
Table 24: European Market for Pain Management Patches, by Category of Pain, Through 2023
Table 25: European Market for Pain Management Patches, by Country, Through 2023
Table 26: Asia-Pacific Market for Pain Management Patches, by the Drug Used, Through 2023
Table 27: Asia-Pacific Market for Pain Management Patches, by Major Segment, Through 2023
Table 28: Asia-Pacific Market for Pain Management Patches, by Category of Pain, Through 2023
Table 29: Asia-Pacific Market for Pain Management Patches, by Country, Through 2023
Table 30: Rest of the World Market for Pain Management Patches, by the Drug Used, Through 2023
Table 31: Rest of the World Market for Pain Management Patches, by Major Segment, Through 2023
Table 32: Rest of the World Market for Pain Management Patches, by Category of Pain, Through 2023
Table 33: Endo Pharmaceuticals Inc.: Pain Management Patches Product Portfolio
Table 34: GlaxoSmithKline PLC: Pain Management Patches Product Portfolio
Table 35: Grunenthal: Pain Management Patches Product Portfolio
Table 36: Hisamitsu Pharmaceutical Co. Inc.: Pain Management Patches Product Portfolio
Table 37: ICURE Pharma Inc.: Pain Management Patches Product Portfolio
Table 38: Johnson & Johnson: Pain Management Patches Product Portfolio
Table 39: Mylan N.V.: Pain Management Patches Product Portfolio
Table 40: Novartis AG: Pain Management Patches Product Portfolio
Table 41: Pfizer Inc.: Pain Management Patches Product Portfolio
Table 42: Sanofi: Pain Management Patches Product Portfolio
Table 43: Sparsha Pharma International Pvt. Ltd.: Pain Management Patches Product Portfolio
Table 44: Teva Pharmaceutical Industries Ltd.: Pain Management Patches Product Portfolio
Table 45: Acronyms Used in This Report

LIST OF FIGURES

Summary Figure: Global Market Shares of Pain Management Patches, by the Drug Used, 2017
Figure 1: Prevalence of Pain at Different Sites of the Body, 2014
Figure 2: Prevalence Rates of Chronic Pain in Different Age Groups, 2015 and 2016
Figure 3: Identified Non-opioid Drug Distribution, by Indication, 2017
Figure 4: Global Market Shares of Pain Management Patches, by the Drug Used, 2017
Figure 5: Global Market for Fentanyl Pain Management Patches, 2017-2023
Figure 6: Global Market for Fentanyl Pain Management Patches, by Region, 2017-2023
Figure 7: Global Market for Buprenorphine Pain Management Patches, 2017-2023
Figure 8: Global Market for Buprenorphine Pain Management Patches, by Region, 2017-2023
Figure 9: Global Market for Lidocaine Pain Management Patches, 2017-2023
Figure 10: Global Market for Lidocaine Pain Management Patches, by Region, 2017-2023
Figure 11: Global Market for Diclofenac Pain Management Patches, 2017-2023
Figure 12: Global Market for Diclofenac Pain Management Patches, by Region, 2017-2023
Figure 13: Global Market for Ketoprofen Pain Management Patches, 2017-2023
Figure 14: Global Market for Ketoprofen Pain Management Patches, by Region, 2017-2023
Figure 15: Global Market for Capsaicin Pain Management Patches, 2017-2023
Figure 16: Global Market for Capsaicin Pain Management Patches, by Region, 2017-2023
Figure 17: Global Market for Methyl Salicylate Pain Management Patches, 2017-2023
Figure 18: Global Market for Methyl Salicylate Pain Management Patches, by Region, 2017-2023
Figure 19: Global Market for Menthol Pain Management Patches, 2017-2023
Figure 20: Global Market for Menthol Pain Management Patches, by Region, 2017-2023
Figure 21: Global Market for Other Types of Pain Management Patches, 2017-2023
Figure 22: Global Market for Other Types of Pain Management Patches, by Region, 2017-2023
Figure 23: Global Market for Over-the-Counter Pain Management Patches, 2017-2023
Figure 24: Global Market for Over-the-Counter Pain Management Patches, by Region, 2017-2023
Figure 25: Global Market for Prescription Pain Management Patches, 2017-2023
Figure 26: Global Market for Prescription Pain Management Patches, by Region, 2017-2023
Figure 27: Global Market for Pain Management Patches for Acute Pain, 2017-2023
Figure 28: Global Market for Pain Management Patches for Acute Pain, by Region, 2017-2023
Figure 29: Global Market for Pain Management Patches for Chronic Pain, 2017-2023
Figure 30: Global Market for Pain Management Patches for Chronic Pain, by Region, 2017-2023
Figure 31: Global Market Shares of Pain Management Patches, by Region, 2017
Figure 32: North American Market Shares of Pain Management Patches, by the Drug Used, 2017
Figure 33: North American Market Shares of Pain Management Patches, by Major Segment, 2017
Figure 34: North American Market Shares of Pain Management Patches, by Category of Pain, 2017
Figure 35: North American Market Shares of Pain Management Patches, by Country, 2017
Figure 36: U.S. Market for Pain Management Patches, 2017-2023
Figure 37: Canadian Market for Pain Management Patches, 2017-2023
Figure 38: Canadian Cancer Statistics, 2019
Figure 39: European Market Shares of Pain Management Patches, by the Drug Used, 2017
Figure 40: European Market Shares of Pain Management Patches, by Major Segment, 2017
Figure 41: European Market Shares of Pain Management Patches, by Category of Pain, 2017
Figure 42: European Market Shares of Pain Management Patches, by Country, 2017
Figure 43: German Market for Pain Management Patches, 2017-2023
Figure 44: French Market for Pain Management Patches, 2017-2023
Figure 45: U.K. Market for Pain Management Patches, 2017-2023
Figure 46: Italian Market for Pain Management Patches, 2017-2023
Figure 47: Spanish Market for Pain Management Patches, 2017-2023
Figure 48: Rest of European Market for Pain Management Patches, 2017-2023
Figure 49: Asia-Pacific Market Shares of Pain Management Patches, by the Drug Used, 2017
Figure 50: Asia-Pacific Market Shares of Pain Management Patches, by Major Segment, 2017
Figure 51: Asia-Pacific Market Shares of Pain Management Patches, by Category of Pain, 2017
Figure 52: Asia-Pacific Market Shares of Pain Management Patches, by Country, 2017
Figure 53: Japanese Market for Pain Management Patches, 2017-2023
Figure 54: Chinese Market for Pain Management Patches, 2017-2023
Figure 55: Indian Market for Pain Management Patches, 2017-2023
Figure 56: Australian and New Zealand Market for Pain Management Patches, 2017-2023
Figure 57: Rest of Asia-Pacific Market for Pain Management Patches, 2017-2023
Figure 58: Rest of the World Market for Pain Management Patches, 2017-2023
Figure 59: Rest of the World Market Shares of Pain Management Patches, by the Drug Used, 2017
Figure 60: Rest of the World Market Shares of Pain Management Patches, by Major Segment, 2017
Figure 61: Rest of the World Market Shares of Pain Management Patches, by Category of Pain, 2017
Figure 62: China SFDA Drug Regulatory Approval Process
Figure 63: Global Market Shares of Pain Management Patches, by Company, 2017
Figure 64: Endo Pharmaceuticals Inc.: Annual Revenue, 2016-2019
Figure 65: Endo Pharmaceuticals Inc.: Revenue Shares, by Established Product, 2019
Figure 66: GlaxoSmithKline PLC: Annual Revenue, 2016-2019
Figure 67: GlaxoSmithKline PLC: Revenue Shares, by Consumer Healthcare, 2019
Figure 68: Hisamitsu Pharmaceutical Co. Inc.: Pharmaceutical Segment Annual Revenue, 2016-2019
Figure 69: Hisamitsu Pharmaceutical Co. Inc.: Revenue Shares, by Region, 2019
Figure 70: Johnson & Johnson: Annual Revenue, 2016-2019
Figure 71: Johnson & Johnson: Revenue Shares, by Region, 2019
Figure 72: Johnson & Johnson: Revenue Shares, by Business Unit, 2019
Figure 73: Mylan N.V.:Annual Revenue, 2016-2019
Figure 74: Mylan N.V.: Revenue Shares, by Region, 2019
Figure 75: Mylan N.V.: Revenue Shares, by Business Unit, 2019
Figure 76: Novartis AG: Annual Revenue, 2015-2019
Figure 77: Novartis AG: Revenue Shares, by Region, 2019
Figure 78: Novartis AG: Revenue Shares, by Business Segment, 2019
Figure 79: Pfizer Inc.: Annual Revenue, 2016-2019
Figure 80: Pfizer Inc.: Revenue Shares, by Region, 2019
Figure 81: Pfizer Inc.: Revenue Shares, by Business Segment, 2019
Figure 82: Sanofi.: Annual Revenue, 2016-2019
Figure 83: Sanofi: Revenue Shares, by Region, 2019
Figure 84: Sanofi: Revenue Shares, by Segment, 2019
Figure 85: Teva Pharmaceutical Industries Ltd.: Generic Segment Annual Revenue, 2016-2019
Figure 86: Teva Pharmaceutical Industries Ltd.: Revenue Shares, by Region, 2019


More Publications